Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Locally Advanced Breast Cancer|Unresectable Breast Carcinoma|Metastatic Breast Cancer|PD-L1 Gene Mutation
Interventions: DRUG: Nab-paclitaxel|DRUG: Paclitaxel|RADIATION: Radiation Therapy|DRUG: Pembrolizumab
Sponsor: University of Colorado, Denver
Collaborators: Cancer League of Colorado